The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 6003 -6010
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803833

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Pericolini, E.
Right arrow Articles by Vecchiarelli, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pericolini, E.
Right arrow Articles by Vecchiarelli, A.

Involvement of Glycoreceptors in Galactoxylomannan-Induced T Cell Death1

Eva Pericolini2,*, Elena Gabrielli2,*, Elio Cenci*, Magdia De Jesus{dagger}, Francesco Bistoni*, Arturo Casadevall{dagger} and Anna Vecchiarelli3,*

* Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy; and {dagger} Department of Microbiology and Immunology of the Albert Einstein College of Medicine, Bronx, New York 10461

The major virulence factor of Cryptococcus neoformans is its capsular polysaccharide, which is also released into tissues. The shed polysaccharide is composed of glucuronoxylomannan, galactoxylomannan (GalXM), and mannoproteins. In a previous study, we demonstrated a direct interaction of purified soluble GalXM with T cells that induced their apoptosis. In this study, we focus on the mechanisms involved in the apoptotic effect of GalXM. In our experimental system, we analyzed the effect of GalXM on purified human T cells and Jurkat cells, a T cell line routinely used for apoptotic studies. Our results reveal that GalXM activates the extrinsic and intrinsic apoptotic pathways through the cleavage and recruitment of caspase-8. Caspase-8 elicits the downstream executioner caspase-3, caspase-6, and caspase-7 both directly and indirectly, via Bid cleavage and caspase-9 activation. These effects appeared to be primarily mediated by the interaction of GalXM with the glycoreceptors, which differed in human T and Jurkat cells. CD45 was primarily involved in Jurkat cells apoptosis while CD7 and CD43 mediated human T cell apoptosis. Our results highlight a new mechanism by which a microbial product can contribute to virulence through direct interaction with T cell glycoreceptors, thereby triggering lymphocyte apoptosis.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Public Health Service Grant AI14209 from the National Institutes of Health and Investment for Basic Research, protocol No. RBLA03C9F4_006. A.C. and M.D.J. were supported by National Institutes of Health Grants R01AI033774-15, R01HL059842-12, and R37AI033142.

2 E.P. and E.G. contributed equally to the paper.

3 Address correspondence and reprint requests to Prof. Anna Vecchiarelli, Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, Perugia, Italy. E-mail address: vecchiar{at}unipg.it

4 Abbreviations used in this paper: GXM, glucuronoxylomannan; GalXM, galactoxylomannan; FasL, Fas ligand; PI, propidium iodide; RT, room temperature; FB, fluorescence buffer; tBid, truncated Bid.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. De Jesus, A. M. Nicola, S. Frases, I. R. Lee, S. Mieses, and A. Casadevall
Galactoxylomannan-Mediated Immunological Paralysis Results from Specific B Cell Depletion in the Context of Widespread Immune System Damage
J. Immunol., September 15, 2009; 183(6): 3885 - 3894.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.